Brief: Aziyo Biologics Reports Strong Third Quarter 2022 Revenue

Elutia

14/11/2022 21:19

Nov 14 (Reuters) - Aziyo Biologics Inc  AZYO.O :
    * AZIYO BIOLOGICS REPORTS STRONG THIRD QUARTER 2022 REVENUE
    * Q3 SALES ROSE 8 PERCENT TO $12.4 MILLION
    * SEES TOTAL NET SALES FOR THE FULL YEAR 2022 IN THE RANGE
OF $48
MILLION TO $50 MILLION
    * QTRLY NET LOSS PER SHARE BASIC AND DILUTED $0.73
    * Q3 EARNINGS PER SHARE VIEW $-0.66, REVENUE VIEW $12.4
MILLION --
REFINITIV IBES DATA
    * FY2022 REVENUE VIEW $49.3 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6yC50C 
Further company coverage:  AZYO.O 
 ((Reuters.Briefs@thomsonreuters.com;))